Advertisement
Advertisement
U.S. markets close in 7 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Perrigo Company plc (PRGO)

NYSE - Nasdaq Real Time Price. Currency in USD
31.76-0.05 (-0.14%)
As of 03:53PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close31.81
Open31.74
Bid31.63 x 800
Ask31.64 x 800
Day's Range31.01 - 31.96
52 Week Range31.01 - 43.90
Volume1,304,301
Avg. Volume1,315,712
Market Cap4.277B
Beta (5Y Monthly)0.93
PE Ratio (TTM)N/A
EPS (TTM)-0.82
Earnings DateNov 08, 2022
Forward Dividend & Yield1.04 (3.16%)
Ex-Dividend DateDec 01, 2022
1y Target Est49.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-59% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PRGO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Perrigo Company plc
    Analyst Report: Perrigo Company PLCPerrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $5 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Yahoo Finance Video

    Reckitt Benckiser expects baby formula shortage to continue into spring 2023

    Yahoo Finance health care reporter Anjalee Khemlani shares the latest on the ongoing baby formula shortage and how it may extend into spring 2023.

  • TipRanks

    ‘Long-term investors should turn back toward stocks’: J.P. Morgan says inflation has peaked and suggests 2 stocks to buy

    For well over a year now, we’ve been seeing headlines about inflation. The rate of price increases is running at its highest level since the early 1980s, although the October numbers, just released, showed it cooling off to 7.7% over the past 12 months. Covering the markets from investment giant JPMorgan, asset management investment chief David Kelly believes the trends are favorable looking forward. From June to October, the annualized inflation rate dropped from 9.1% to 7.7%, leading him to sa

  • Motley Fool

    Why Perrigo Stock Tanked on Tuesday

    Drug company Perrigo (NYSE: PRGO) experienced quite a headache on Tuesday after it released its third-quarter report before the bell. For the period, Perrigo booked total sales of $1.1 billion, which was nearly 6% higher on a year-over-year basis. Perrigo has a wide range of products in its portfolio.

Advertisement
Advertisement